InsiderTrades

Form 4 for HCA HCA Healthcare

Accepted 2025-11-05 00:00:00 ET · period of report 2025-11-03 · accession 0001193125-25-267409 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-11-05 2025-11-05 HCA McAlevey Michael R EVP, Chief Legal, Admin Off S - Sale+OE $473.79 -3,892 3,487 -53% -$1.84M
D 2025-11-05 2025-11-03 HCA McAlevey Michael R EVP, Chief Legal, Admin Off M - OptEx $236.61 +13.2K 16.7K +378% +$3.12M
D 2025-11-05 2025-11-03 HCA McAlevey Michael R EVP, Chief Legal, Admin Off F - Tax $461.56 -9,278 7,379 -56% -$4.28M
D 2025-11-05 2025-11-03 HCA McAlevey Michael R EVP, Chief Legal, Admin Off M - OptEx $0.00 -13.2K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-11-05 S D 3,892 $473.79 3,487 D — —
2 Common Common Stock 2025-11-03 M A 13,170 $236.61 16,657 D — —
3 Common Common Stock 2025-11-03 F D 9,278 $461.56 7,379 D — —
4 Derivative Stock Appreciation Right 2025-11-03 M D 13,170 $0.00 0 D $236.61 · — to 2032-01-28 13,170 Common Stock (F2) The stock appreciation rights vested in two equal annual installments beginning on January 28, 2023.